Literature DB >> 12542742

Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis.

R Tazi-Ahnini1, M J Cork, D J Gawkrodger, M P Birch, D Wengraf, A J G McDonagh, A G Messenger.   

Abstract

Alopecia areata is characterized by a reversible form of patchy or complete hair loss associated with T-cell infiltration of hair follicles. The lifetime disease risk of approximately 1.4% in the general population is increased to more than 30% in autoimmune polyendocrinopathy candidiasis ectodermal dysplasia syndrome (APECED), a recessive condition resulting from a mutation of the autoimmune regulator (AIRE) gene on chromosome 21q22.3. Aire protein is thought to have transcriptional regulatory activity but its role is not well defined at present. In this study, we have examined the possible involvement of AIRE in the pathogenesis of alopecia areata. On screening the AIRE coding sequence, we identified 20 variants. Two of these at positions, G961C and T1029C, give rise to amino acid changes, S278R and V301A, located in the DNA-binding segment (SAND) and PHD1 zinc finger motif, respectively. We found no difference in the frequency of the AIRE T1029C polymorphism between the control and patient groups. We genotyped 202 alopecia areata patients and 175 matched Caucasian controls for the AIRE G961C alleles. The frequency of the rare allele (961G) was 0.08 in the controls and there was a significant increase to 0.13 in alopecia areata overall and 0.20 in severe disease (alopecia universalis). We found no association between the AIRE G961G variant and mild (patchy) alopecia areata or alopecia totalis. However, the AIRE 961G allele is a potent risk factor (> 3) for the severest form of alopecia areata, and for disease of early age at onset (at 30 years). The change from serine to arginine in the SAND domain of AIRE protein may have a significant effect on AIRE DNA-binding activity. Moreover, our results could provide a rational explanation of the unusually high frequency of AA in APECED patients, supporting the concept of AA as an autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12542742     DOI: 10.1034/j.1399-0039.2002.600604.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  16 in total

Review 1.  The role of lymphocytes in the development and treatment of alopecia areata.

Authors:  Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal:  Expert Rev Clin Immunol       Date:  2015-09-07       Impact factor: 4.473

Review 2.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Dominant-negative loss of function arises from a second, more frequent variant within the SAND domain of autoimmune regulator (AIRE).

Authors:  Jordan K Abbott; Yu-San Huoh; Paul R Reynolds; Liping Yu; Marian Rewers; Monica Reddy; Mark S Anderson; Sun Hur; Erwin W Gelfand
Journal:  J Autoimmun       Date:  2017-11-10       Impact factor: 7.094

Review 4.  Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.

Authors:  A Sterkens; J Lambert; A Bervoets
Journal:  Clin Exp Med       Date:  2021-01-01       Impact factor: 3.984

5.  The S100A7 nuclear interactors in autoimmune diseases: a coevolutionary study in mammals.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Massimo Libra
Journal:  Immunogenetics       Date:  2022-02-16       Impact factor: 2.846

6.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Association analysis of the AIRE and insulin genes in Finnish type 1 diabetic patients.

Authors:  Joni A Turunen; Maija Wessman; Carol Forsblom; Riika Kilpikari; Maija Parkkonen; Nora Pöntynen; Tanja Ilmarinen; Ismo Ulmanen; Leena Peltonen; Per-Henrik Groop
Journal:  Immunogenetics       Date:  2006-03-22       Impact factor: 2.846

Review 8.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

Review 9.  Monogenic autoimmune diseases: insights into self-tolerance.

Authors:  Maureen A Su; Mark S Anderson
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

10.  Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata.

Authors:  Seok-Beom Hong; Sheng-Yu Jin; Hae-Jeong Park; Joo-Ho Jung; Woo-Young Sim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.